Department of Cardiothoracic Surgery, Heart and Vascular Center, Maastricht University Medical Centre, Maastricht, The Netherlands; Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Palermo, Italy.
Clinical Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior in Warsaw, Warsaw, Poland; Cardiothoracic Research Center, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
Ann Thorac Surg. 2019 Jan;107(1):311-321. doi: 10.1016/j.athoracsur.2018.05.063. Epub 2018 Jun 28.
Venoarterial (VA) extracorporeal membrane oxygenation (ECMO) application in postcardiotomy shock (PCS) and non-PCS is increasing. VA-ECMO plays a critical role in the management of these patients, yet may be associated with serious complications.
A systematic review of all available reports in the literature of patients receiving VA-ECMO, either directly or indirectly, comparing central cannulation (right atrial to ascending aorta) versus peripheral cannulation (femoral vein to femoral artery or axillary artery) were analyzed. The primary endpoint was survival. Cerebrovascular events, limb complications, bleeding requiring reoperation, sepsis, continuous venovenous hemofiltration, and transfusions were also assessed in both groups.
Seventeen retrospective case series clearly describing the VA-ECMO access and including 1,691 patients with PCS and non-PCS were found. The peripheral approach was more commonly used (980 patients, 57.9%) than the central one. There was no difference in the analysis between the two techniques regarding all-cause mortality risk ratio (1.00, 95% confidence interval: 0.94 to 1.08, I = 0%, p = 0.92). No statistical differences were found between peripheral and central VA-ECMO with regard to cerebrovascular events, limb complications, or sepsis rates. Peripheral cannulation was associated with a significant reduction in the risk of bleeding (p = 0.02), continuous venovenous hemofiltration (p = 0.03), transfusion of red blood cells units (p < 0.00001), fresh frozen plasma units (p = 0.0002), and platelets units (p < 0.00001).
Peripheral and central VA-ECMO configurations showed comparable inhospital survival for PCS and non-PCS. The risk of bleeding, continuous venovenous hemofiltration, and blood product transfusion was significantly lower with the peripheral cannulation strategy.
静脉-动脉(VA)体外膜肺氧合(ECMO)在心脏手术后休克(PCS)和非 PCS 患者中的应用正在增加。VA-ECMO 在这些患者的治疗中起着至关重要的作用,但可能与严重并发症有关。
对文献中所有接受 VA-ECMO 治疗的患者的报告进行系统回顾,这些患者直接或间接接受中央置管(右心房至升主动脉)或外周置管(股静脉至股动脉或腋动脉)治疗。主要终点是存活率。两组患者还评估了脑血管事件、肢体并发症、需要再次手术的出血、脓毒症、连续静脉-静脉血液滤过和输血。
共发现 17 项明确描述 VA-ECMO 入路的回顾性病例系列研究,共纳入 1691 例 PCS 和非 PCS 患者。外周入路(980 例,57.9%)比中央入路更常用。两种技术之间的全因死亡率风险比分析没有差异(1.00,95%置信区间:0.94 至 1.08,I=0%,p=0.92)。在外周和中央 VA-ECMO 之间,在脑血管事件、肢体并发症或脓毒症发生率方面没有发现统计学差异。外周置管与出血风险降低显著相关(p=0.02)、连续静脉-静脉血液滤过(p=0.03)、红细胞单位输血(p<0.00001)、新鲜冷冻血浆单位输血(p=0.0002)和血小板单位输血(p<0.00001)。
外周和中央 VA-ECMO 构型在 PCS 和非 PCS 患者中显示出相似的住院生存率。外周置管策略的出血、连续静脉-静脉血液滤过和血液制品输血风险显著降低。